NYSE: Corporate Board Member Online
Mitigating the Risks of Stockholder Litigation in M&A Transactions
July 31, 2015
The statistics are remarkable. Virtually every merger transaction nowadays involving a public company will be the subject of stockholder litigation. That is true regardless of the size of the deal, the size of the premium, the form of the transaction, the identity of the parties or the care with which the board proceeded. Often, plaintiffs' firms announce “investigations” of transactions within a matter of hours of the announcement of a transaction—and sometimes within minutes. Given the near certainty that your deal will be the subject of litigation, this article provides a few common sense ways to mitigate exposure and to ensure that the inevitable lawsuits result in minimal disruption.
Contacts
Capabilities
Suggested News & Insights
Sidley Represents Werewolf Therapeutics in Merger with Ambros Therapeutics and Concurrent US$150 Million Private PlacementAugust 21, 2026Sidley Represents Stone Point Capital in Acquisition of Ever.Ag’s Risk Management BusinessAugust 20, 2026Sidley Represents Clearlake Capital Group in Its Investment in Databricks’ US$5 Billion Funding RoundAugust 19, 2026Sidley Represents Ridgeview Partners in Its Proposed £545 Million Acquisition of Pinewood TechnologiesAugust 19, 2026Mind the Gap: Delaware Court of Chancery’s Clarification of the Implied Covenant’s Contractual Gap-Filling RoleAugust 18, 2026Sidley Earns Three Finalist Recognitions in The American Lawyer Industry Awards 2026August 17, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
